Patent ID: 9623104
Date: 2017-04-18
CPC Classifications: A61K,A61P,C07K,C12N

Claim:
1. A vaccine comprising (i) a first influenza virus-like particle (VLP) wherein the first VLP comprises influenza proteins consisting of a HA protein and an NA protein from a first influenza strain, and an M1 protein from the influenza strain A/Indonesia/5/05; and (ii) a second influenza VLP wherein the second VLP comprises influenza proteins consisting of a HA protein and an NA protein from a second influenza strain, and an M1 protein from the influenza strain A/Indonesia/5/05; and (iii) a pharmaceutically acceptable carrier or excipient; wherein the first and second influenza strains are different from A/Indonesia/5/05, and wherein the first influenza strain is different from the second influenza strain.